Chatham Rock Phosphate Balance Sheet Health

Financial Health criteria checks 5/6

Chatham Rock Phosphate has a total shareholder equity of CA$6.6M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$7.0M and CA$412.2K respectively.

Key information

Debt to equity ratio

CA$0

Debt

Interest coverage ratio	n/a
Cash	CA$167.15k
Equity	CA$6.60m
Total liabilities	CA$412.17k
Total assets	CA$7.01m

Recent financial health updates

Recent updates

Financial Position Analysis

Short Term Liabilities: NZP's short term assets (CA$243.0K) do not cover its short term liabilities (CA$390.2K).

Long Term Liabilities: NZP's short term assets (CA$243.0K) exceed its long term liabilities (CA$22.0K).

Debt to Equity History and Analysis

Debt Level: NZP is debt free.

Reducing Debt: NZP had no debt 5 years ago.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NZP has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: NZP is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.

Chatham Rock Phosphate Balance Sheet Health

Financial Health criteria checks 5/6

Key information

Recent financial health updates

Chatham Rock Phosphate Limited Auditor Raises 'Going Concern' Doubt

Recent updates

Chatham Rock Phosphate Limited announced that it expects to receive NZD 0.59375 million in funding

Chatham Rock Phosphate Limited, Annual General Meeting, Nov 15, 2024

Chatham Rock Phosphate Limited announced that it has received NZD 0.140556 million in funding

Insufficient new directors

Third quarter 2024 earnings released: CA$0.004 loss per share (vs CA$0.003 loss in 3Q 2023)

Chatham Rock Phosphate Limited announced that it has received CAD 0.436294 million in funding

First half 2024 earnings released: CA$0.011 loss per share (vs CA$0.01 loss in 1H 2023)

Chatham Rock Phosphate Limited announced that it expects to receive CAD 0.7 million in funding

Chatham Rock Phosphate Limited Provides Update on Its Lead Project Korella North

Chatham Rock Phosphate Limited Announces Maiden Mineral Resource Estimate for the Korella North Phosphate Property in Queensland, Australia

New major risk - Revenue and earnings growth

Full year 2023 earnings released: CA$0.021 loss per share (vs CA$0.016 loss in FY 2022)

New minor risk - Shareholder dilution

Chatham Rock Phosphate Limited announced that it has received NZD 0.828591 million in funding

Chatham Rock Phosphate Limited Announces the Korella North Mine Planning and Marketing Advances

Third quarter 2023 earnings released: CA$0.003 loss per share (vs CA$0.006 loss in 3Q 2022)

Chatham Rock Phosphate Limited Announces Work Programme Approve for CRP's Pacific Rare Earths Selenium Exploration Permit At Gunnerside

Chatham Rock Phosphate Limited Grants Pacific Rare Earths Tambo Selenium Exploration Permit

Second quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.003 loss in 2Q 2022)

Chatham Rock Phosphate Limited Announces Approval from Queensland Department of Resources for Exploration Work in the Tambo Region of Central West Queensland

Chatham Rock Phosphate Limited Advances Korella North Project

Chatham Rock Phosphate Limited Announces Preliminary Phosphate Ore Sorting Results

First quarter 2023 earnings released: CA$0.005 loss per share (vs CA$0.004 loss in 1Q 2022)

Chatham Rock Phosphate Limited Continues to Enlarge Resource Asset Base with New Prospect in Queensland

Chatham Rock Phosphate Limited Applies for Korella North Exploration Permit

Full year 2022 earnings released: CA$0.016 loss per share (vs CA$0.017 loss in FY 2021)

Chatham Rock Phosphate Limited, Annual General Meeting, Nov 17, 2022

Chatham Rock Phosphate Limited Reports Encouraging Dicalcium Phosphate Test Results

Chatham Rock Phosphate Limited Provides Pacific Rare Earths Progress Report

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Chatham Rock Phosphate Limited announced that it has received NZD 0.900125 million in funding from General Research GmbH

First quarter 2022 earnings released: CA$0.004 loss per share (vs CA$0.004 loss in 1Q 2021)

Chatham Rock Phosphate Limited announced that it expects to receive NZD 1.125 million in funding

High number of new directors

Full year 2021 earnings released: CA$0.017 loss per share (vs CA$0.025 loss in FY 2020)

Chatham Rock Phosphate Limited announced that it has received NZD 0.380812 million in funding

Chatham Rock Phosphate Limited (NZSE:CRP) completed the acquisition of Avenir Makatea Pty Ltd.

Chatham Rock Phosphate Limited announced that it has received NZD 0.72 million in funding

Third quarter 2021 earnings released: CA$0.003 loss per share (vs CA$0.005 loss in 3Q 2020)

Chatham Rock Phosphate Limited announced that it has received NZD 0.7 million in funding

Chatham Rock Phosphate Limited (NZSE:CRP) agreed to acquire Avenir Makatea Pty Ltd for CAD 1.5 million.

Chatham Rock Phosphate Limited announced that it expects to receive NZD 0.7 million in funding

Second quarter 2021 earnings released: CA$0.004 loss per share

First quarter earnings released

Chatham Rock Phosphate Limited Auditor Raises 'Going Concern' Doubt

Financial Position Analysis

Debt to Equity History and Analysis

Balance Sheet

Cash Runway Analysis

Discover healthy companies